Cocrystal Pharma, Inc. Appoints Anthony Japour as Director
April 09, 2019 at 04:30 pm EDT
On April 4, 2019, the Board of Directors of Cocrystal Pharma, Inc. appointed Dr. Anthony Japour as a director to fill a vacancy on the Board, effective immediately. Dr. Japour was designated by Dr. Raymond Schinazi, principal stockholder, pursuant to the Stockholder Rights Agreement, dated November 24, 2014. Dr. Japour was also appointed as a member of the Compensation Committee and the Corporate Governance and Nominating Committee of the Board, effective immediately. Anthony Japour, has served as a Medical Director of ICON plc since February 2016.